Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. May 16, 2016; 4(5): 127-129
Published online May 16, 2016. doi: 10.12998/wjcc.v4.i5.127
Published online May 16, 2016. doi: 10.12998/wjcc.v4.i5.127
Cardiac resynchronisation therapy after percutaneous mitral annuloplasty
Janice Swampillai, Department of Cardiology, Waikato Hospital, Hamilton 3240, New Zealand
Author contributions: Swampillai J was involved in this case and wrote this report.
Conflict-of-interest statement: There are no conflicts of interest to report.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Janice Swampillai, MBBS, FRACP, MD, Department of Cardiology, Waikato Hospital, Level 2 Waiora, Pembroke Street, Private Bag 3200, Hamilton 3240, New Zealand. janice.swampillai@waikatodhb.health.nz
Telephone: +64-7-8398899 Fax: +64-7-8398639
Received: January 20, 2016
Peer-review started: January 20, 2016
First decision: February 2, 2016
Revised: February 14, 2016
Accepted: March 22, 2016
Article in press: March 23, 2016
Published online: May 16, 2016
Processing time: 93 Days and 22.2 Hours
Peer-review started: January 20, 2016
First decision: February 2, 2016
Revised: February 14, 2016
Accepted: March 22, 2016
Article in press: March 23, 2016
Published online: May 16, 2016
Processing time: 93 Days and 22.2 Hours
Abstract
Percutaneous approaches to reduce mitral regurgitation in ischemic cardiomyopathy have stirred interest recently. Patients with ischemic cardiomyopathy and functional mitral regurgitation often meet criteria for cardiac resynchronisation therapy to improve left ventricular function as well as mitral regurgitation, and alleviate symptoms. This case shows that implantation of a pacing lead in the coronary sinus to restore synchronous left and right ventricular contraction is feasible, despite the presence of a remodeling device in the coronary sinus.
Keywords: Mitral regurgitation; Cardiac implantable electronic device; Percutaneous mitral regurgitation; Ischemic cardiomyopathy; Cardiac resynchronisation therapy
Core tip: A review of cardiac resynchronisation therapy in a patient with ischemic cardiomyopathy and previous percutaneous mitral annuloplasty using a remodeling device in the coronary sinus.